Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, December 17, 2020
[ Thu, Dec 17th 2020
] - WOPRAI
[ Thu, Dec 17th 2020
] - WOPRAI
[ Thu, Dec 17th 2020
] - WOPRAI
[ Thu, Dec 17th 2020
] - WOPRAI
[ Thu, Dec 17th 2020
] - WOPRAI
[ Thu, Dec 17th 2020
] - WOPRAI
[ Thu, Dec 17th 2020
] - WOPRAI
[ Thu, Dec 17th 2020
] - WOPRAI
[ Thu, Dec 17th 2020
] - WOPRAI
[ Thu, Dec 17th 2020
] - WOPRAI
[ Thu, Dec 17th 2020
] - WOPRAI
[ Thu, Dec 17th 2020
] - WOPRAI
[ Thu, Dec 17th 2020
] - WOPRAI
[ Thu, Dec 17th 2020
] - WOPRAI
Wed, December 16, 2020
[ Wed, Dec 16th 2020
] - WOPRAI
[ Wed, Dec 16th 2020
] - WOPRAI
[ Wed, Dec 16th 2020
] - WOPRAI
[ Wed, Dec 16th 2020
] - WOPRAI
[ Wed, Dec 16th 2020
] - WOPRAI
[ Wed, Dec 16th 2020
] - WOPRAI
[ Wed, Dec 16th 2020
] - WOPRAI
Esther Hong Initiated (SPRO) at Strong Buy and Held Target at $47 on, Dec 16th, 2020
Esther Hong of Berenberg, Initiated "Spero Therapeutics, Inc." (SPRO) at Strong Buy and Held Target at $47 on, Dec 16th, 2020.
Esther has made no other calls on SPRO in the last 4 months.
There are 2 other peers that have a rating on SPRO. Out of the 2 peers that are also analyzing SPRO, 0 agree with Esther's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Esther
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $33 on, Monday, November 23rd, 2020
- Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $70 on, Tuesday, September 29th, 2020
